CheckMyRecalls

Glenmark Pharmaceuticals Inc., USA recalls Carvedilol Tablets

Published
20 Aug 2025
Units affected
2 products
Agency
FDA
Country
United States

The hazard

CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Carvedilol Tablets, USP, 25 mg, 500 Tablets per carton, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot No. 2, Phase-2, Pharma Zone SEZ, Pithampur, Dist.-Dhar, Madhya Pradesh 454 775, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 47430 NDC: 68462-165-05

Carvedilol Tablets, USP, 12.5 mg, 500 Tablets per carton, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot No. 2, Phase-2, Pharma Zone SEZ, Pithampur, Dist.-Dhar, Madhya Pradesh 454 775, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 47430, NDC 68462-164-05

Brand / company
Glenmark Pharmaceuticals Inc., USA
Codes / lots
Lot #: 17241213, 17241215, 17241224, Exp. Date 06/2026 | Lot #: 17241257, 17241258, 17241279, Exp. Date 06/2026
Distribution
Nationwide within the USA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 20 Aug 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.